NO20022290L - Aryloxypropanolamines for improving livestock breeding - Google Patents

Aryloxypropanolamines for improving livestock breeding

Info

Publication number
NO20022290L
NO20022290L NO20022290A NO20022290A NO20022290L NO 20022290 L NO20022290 L NO 20022290L NO 20022290 A NO20022290 A NO 20022290A NO 20022290 A NO20022290 A NO 20022290A NO 20022290 L NO20022290 L NO 20022290L
Authority
NO
Norway
Prior art keywords
structural formula
independently
ring
straight
chain
Prior art date
Application number
NO20022290A
Other languages
Norwegian (no)
Other versions
NO20022290D0 (en
Inventor
Randall Bruce Hopkins
Michael Eugene Quimby
John Arnold Werner
Dana Lori Hancock
Roger Ryan Rothhaar
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20022290D0 publication Critical patent/NO20022290D0/en
Publication of NO20022290L publication Critical patent/NO20022290L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Feed For Specific Animals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Forbindelse representert ved den strukturelle formel (I): CONR4R5 Hvor RI er en substituert eller usubstituert arylgruppe; R2 og R3 er uavhengig -H, en C1-C4 rettkjedet eller forgrenet alkylgruppe; R4 og R5 er uavhengig -H, en C1-C4 rettkjedet eller forgrenet alkylgruppe eller, tatt sammen med det nitrogenatom til hvilket hver er bundet, danner en ikke-aromatisk heterosyklisk ring; ring A og ring B er uavhengig ytterligere substituert med null, en eller to substituenter. Fysiologisk akseptable salter av den ovenfor angitte strukturformel er også inkludert. Videre beskrives en fremgangsmåte for å fremme vekst, effektivitet av forutnyttelse og/eller produksjon av mager kroppsmasse i et husdyr. Fremgangsmåten innbefatter administrasjon til dyret av en effektiv mengde av en eller flere forbindelser representert ved den angitte strukturformelen eller et fysiologisk akseptabelt salt derav.Compound represented by the structural formula (I): CONR4R5 Where R1 is a substituted or unsubstituted aryl group; R 2 and R 3 are independently -H, a C 1 -C 4 straight-chain or branched alkyl group; R4 and R5 are independently -H, a C1-C4 straight-chain or branched alkyl group or, taken together with the nitrogen atom to which each is attached, forms a non-aromatic heterocyclic ring; ring A and ring B are independently further substituted with zero, one or two substituents. Physiologically acceptable salts of the above structural formula are also included. Furthermore, a method is described for promoting growth, efficiency of pre-utilization and / or production of lean body mass in a livestock. The method includes administering to the animal an effective amount of one or more compounds represented by the indicated structural formula or a physiologically acceptable salt thereof.

NO20022290A 1999-11-15 2002-05-14 Aryloxypropanolamines for improving livestock breeding NO20022290L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16546099P 1999-11-15 1999-11-15
PCT/US2000/031060 WO2001036413A1 (en) 1999-11-15 2000-11-13 Aryloxy propanolamines for improving livestock production

Publications (2)

Publication Number Publication Date
NO20022290D0 NO20022290D0 (en) 2002-05-14
NO20022290L true NO20022290L (en) 2002-07-09

Family

ID=22598982

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022290A NO20022290L (en) 1999-11-15 2002-05-14 Aryloxypropanolamines for improving livestock breeding

Country Status (16)

Country Link
JP (1) JP2003514815A (en)
KR (1) KR20020059730A (en)
CN (1) CN1390213A (en)
AU (1) AU1917401A (en)
BR (1) BR0015578A (en)
CA (1) CA2391654A1 (en)
CO (1) CO5221077A1 (en)
CZ (1) CZ20021644A3 (en)
EA (1) EA200200569A1 (en)
IL (1) IL149570A0 (en)
MX (1) MXPA02004653A (en)
NO (1) NO20022290L (en)
PE (1) PE20010707A1 (en)
PL (1) PL355669A1 (en)
SV (1) SV2002000216A (en)
WO (1) WO2001036413A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103325D0 (en) 2001-10-04 2001-10-04 Astrazeneca Ab Novel compounds
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
US7317023B2 (en) 2004-07-21 2008-01-08 Theravance, Inc. Diaryl ether β2 adrenergic receptor agonists
US20130224320A1 (en) * 2012-02-23 2013-08-29 Joan Torrent Campmany Process to improve feed efficiency and carcass characteristics of animals
CN111925329B (en) * 2020-09-14 2021-01-12 正大预混料（天津）有限公司 Stilbene triphenol derivative and composition, preparation method and application thereof
CN115611752A (en) * 2022-10-21 2023-01-17 江苏天和制药有限公司 Synthetic refining method of lubabylon intermediate
CN117296990B (en) * 2023-08-08 2024-02-23 河南蒜宝生物科技有限公司 Safe and green composite feed additive containing garlic extract and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6075040A (en) * 1996-09-05 2000-06-13 Eli Lilly And Company Selective β3 adrenergic agonists
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
ATE215369T1 (en) * 1996-09-05 2002-04-15 Lilly Co Eli CARBAZOLE ANALOGUES AS SELECTIVE BETA3-ADRENERGIC AGONISTS
CO5011072A1 (en) * 1997-12-05 2001-02-28 Lilly Co Eli ETANOLAMINAS PIRAZINIL SUBSTITUTED AS AGFONISTS OF THE RECEPTORS

Also Published As

Publication number Publication date
PE20010707A1 (en) 2001-07-11
MXPA02004653A (en) 2002-09-02
JP2003514815A (en) 2003-04-22
PL355669A1 (en) 2004-05-04
CZ20021644A3 (en) 2002-10-16
CO5221077A1 (en) 2002-11-28
NO20022290D0 (en) 2002-05-14
IL149570A0 (en) 2002-11-10
CN1390213A (en) 2003-01-08
CA2391654A1 (en) 2001-05-25
WO2001036413A1 (en) 2001-05-25
BR0015578A (en) 2002-07-09
EA200200569A1 (en) 2003-06-26
KR20020059730A (en) 2002-07-13
AU1917401A (en) 2001-05-30
SV2002000216A (en) 2002-07-16

Similar Documents

Publication Publication Date Title
EA200100486A1 (en) DERIVATIVES 2-UREIDOTHIAOSOL, THE WAY OF THEIR RECEPTION AND APPLICATION OF THE SPECIFIED SUBSTANCES AS ANTI-TUMOR MEDICINE
DK0944617T3 (en) Crystals of benzimidazole derivatives and their preparation
DE3850306D1 (en) Camptothecin derivatives and process for their preparation.
KR890008137A (en) Method for preparing 3- [4 (1-substituted-4-piperazinyl) butyl] -4-thiazolidinoyi and use thereof as a medicament
IE822467L (en) Imidazole derivatives
AR241784A1 (en) 2-(n-substituteguanidino)-4-hetero-arylthiazole antiulcer agents
PT88526A (en) L-DOPA DERIVATIVES OR THEIR ACID ADDITION SALTS PROCESS FOR PRODUCING SAME AND THEIR USE
DK616388A (en) QUINOLINCARBOXYLIC ACID DERIVATIVES AND PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF WITH ANTIBACTERIAL EFFECT
DK0518558T3 (en) 1-methylcarbapenem derivatives, their preparation and their use as antibiotics
ES2132135T3 (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICALLY ACTIVE THIAZOLIDINE OR OXAZOLIDINE COMPOUNDS THROUGH A YEAST REDUCTASE.
IE782115L (en) Imidazole derivatives
NO20022290L (en) Aryloxypropanolamines for improving livestock breeding
GB1425354A (en) Indole derivatives
ES411341A1 (en) Hererocyclic derivatives of a guanidine
DK129286A (en) 5-FLUORBENZONITRIL DERIVATIVES AND THEIR PHARMACOLOGICAL ACCEPTABLE ACID ADDITION SALTS
ES8304120A1 (en) Acylaminoquinazoline derivatives, a process for their preparation and a pharmaceutical composition containing them.
RU92016232A (en) DERIVATIVES OF 13- (SUBSTITUTED TIO) -ACETOXYMILBEMICINE, METHOD FOR THEIR PRODUCTION AND AGRICULTURAL COMPOSITION
CA2092919A1 (en) Epoxysuccinamic acid derivatives
NO934227L (en) Pyrrole derivatives, processes for their preparation and therapeutic use
GB1082444A (en) Novel benzdiaz[1,4]epine derivatives and a process for the manufacture thereof
ATE87920T1 (en) KETEN-S,S,-ACETAL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND METHOD FOR CUREING MYCOSIS USING THESE DERIVATIVES.
NO802925L (en) NITROSOURE ADDITIVES AND PROCEDURES FOR PREPARING THEREOF
ATE30718T1 (en) PREPARATION OF 1-BENZYL AZETIDIN-3-OL AND THE CORRESPONDING HALID ACID.
ES8607209A1 (en) Monosilylated aminophenylethyl amine derivatives, process for their preparation and their use for promoting growth.
JPS5585550A (en) 4-homoisotwistane amino acid amide

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application